Positive effects of allosteric modulators on the binding properties and the function of muscarinic acetylcholine receptors

Journal of Physiology Paris

Volumn 92, Issue 3-4, 1998, Pages 241-243

  Tuček, Stanislav ^a   Jakubík, Jan ^a   Doležal, Vladimir ^a   El Fakahany, Esam E ^b  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 METHOXY ALPHA LAPACHONE; BRUCINE; FANGQUINOLINE; GUANINE NUCLEOTIDE BINDING PROTEIN; METHYLSCOPOLAMINE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; QUINUCLIDINYL BENZILATE; STRYCHNINE; TETRANDRINE; TRITIUM; UNCLASSIFIED DRUG; VINBURNINE; VINCAMINE;

ALLOSTERISM; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; RECEPTOR AFFINITY; RECEPTOR BINDING;

EID: 0032105399     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4257(98)80026-0     Document Type: Conference Paper

References (28)

1. [1] Birdsall N.J.M., Farries T., Gharagozloo P., Kobayashi S., Kuonen D., Lazareno S., Popham A., Sugimoto M., Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes, Life Sci. 60 (1997) 1047-1052.
2. [2] Clark A.L., Mitchelson F., The inhibitory effect of gallamine on muscarinic receptors, Br. J. Pharmacol. 58 (1976) 323-331.
3. 3H]acetylcholine release from rat striaturn by muscarinc receptor agonists, Br. J. Pharmacol. (1998), in press.
4. [4] Guo Z.D., Kameyama K., Rinken A., Haga T., Ligand binding properties of muscarinic acetylcholine receptor subtypes (m1-m5) expressed in baculovirus-infected insect cells, J. Pharmacol. Exp. Ther. 274 (1995) 378-384.
5. [5] Guo Z.D., Haga T., Itokawa H., Mizobe F., Allosteric binding of 9-methoxy-alpha-lapachone and alcuronium to the muscarinic acetylcholine receptor m2 subtype, Biomed. Res. 16 (1995) 327-335.
6. [6] Hejnová L., Tuček S., El-Fakahany E.E., Positive and negative allosteric interactions on muscarinic receptors, Eur. J. Pharmacol. 291 (1995) 427-430.
7. [7] Holzgrabe U., Mohr K., Allosteric modulation of ligand binding to muscarinic acetylcholine receptors, Drug Dev. Today 3 (1998) 214-222.
8. [8] Jakubík J., Tuček S., Protection by alcuronium of muscarinic receptors against chemical inactivation and location of the allosteric binding site for alcuronium, J. Neurochem. 63 (1994) 1932-1940.
9. [9] Jakubík J., Tuček S., Two populations of muscarinic binding sites in the chick heart distinguished by affinities for ligands and selective inactivation, Br. J. Pharmacol. 113 (1994) 1529-1537.
10. [10] Jakubík J., Tucek S., Positive allosteric interactions on cardiac muscarinic receptors: effects of chemical modifications of disulphide and carboxyl groups, Eur. J. Pharmacol. 289 (1995) 311-319.
11. 5 muscarinic acetylcholine receptors, J. Pharmacol. Exp. Ther. 274 (1995) 1077-1083.
12. [12] Jakubǐk J., Bačáková L., Lisa V., El-Fakahany E.E., Tuček S., Activation of muscarinic acetylcholine receptors via their allosteric binding sites, Proc. Natl. Acad. Sci. USA 93 (1996) 8705-8709.
13. [13] Jakubík J., Bačáková L., El-Fakahany E.E., Tuček S., Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors, Mol. Pharmacol. 52 (1997) 172-179.
14. [14] Jakubík J., Haga T., Tuček S., Allosteric ligand-receptor-G protein interactions in lipid vesicles, Life Sci. 60 (1997) 1170.
15. [15] Lazareno S., Birdsall N.J.M., Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors, Mol. Pharmacol. 48 (1995) 362-378.
16. [16] Lee N.H., El-Fakahany E.E., Allosteric antagonists of the muscarinic acetylcholine receptor, Biochem. Pharmacol. 42 (1991) 199-205.
17. [17] Leppik R.A., Miller R.C., Eck M., Paquet J.-L., Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor, Mol. Pharmacol. 45 (1994) 983-990.
18. [18] Matsui H., Lazareno S., Birdsall N.J.M., Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis, Mol. Pharmacol. 47 (1995) 88-98.
19. [19] Musílková J., Tucek S., Positive allosteric action of alcuronium on solubilized cardiac muscarinic receptors, Neurochem. Int. 27 (1995) 337-343.
20. [20] Nedoma J., Tuček S., Danilov A.F., Shelkovnikov S.A., Stabilization of antagonist binding to cardiac muscarinic acetylcholine receptors by gallamine and other neuromuscular blocking drugs, J. Pharmacol. Exp. Ther. 236 (1986) 219-223.
21. [21] Nedoma J., Tuček S., Shelkovnikov S., Danilov A., Allosteric effects of gallamine and alcuronium on muscarinic receptors, in: Tuček S. (Ed.), Synaptic Transmitters and Receptors, Academia, Praha, 1987, pp. 108-112.
22. [22] Proska J., Tuček S., Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors, Mol. Pharmacol. 45 (1994) 709-717.
23. [23] Proška J., Tuček S., Competition between positive and negative allosteric effectors on muscarinic receptors, Mol. Pharmacol. 48 (1995) 696-702.
24. [24] Proška J., Tuček S., Positive allosteric action of eburnamonine on cardiac muscarinic acetylcholine receptors, Eur. J. Pharmacol. 305 (1996) 201-205.
25. [25] Stockton J.M., Birdsall N.J.M., Burgen A.S.V., Hulme E.C., Modification of the binding properties of muscarinic receptors by gallamine, Mol. Pharmacol. 23 (1983) 551-557.
26. [26] Tuček S., Is the R and R* dichotomy real?, Trends Pharmacol. Sci. 18 (1997) 414-116.
27. [27] Tuček S., Proška J., Allosteric modulation of muscarinic acetylcholine receptors, Trends Pharmacol. Sci. 16 (1995) 205-212.
28. [28] Tuček S., Musílková J., Nedoma J., Proška J., Shelkovnikov S., Vorlícek J., Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors, Mol. Pharmacol. 38 (1990) 674-680.